As the COVID-19 pandemic reaches into more communities, many hospitals, clinics and providers are being inundated with inquiries from people who are concerned they may have been exposed and need treatment. To prevent healthcare organizations from being overwhelmed by inquiries, and to ensure that only those who truly need help enter the system, it is essential to screen inquiries in a way that assesses an individual’s potential risk, then directs any qualified risk cases to the appropriate resources for next steps.

Microsoft Healthcare Bot is a cloud service that empowers healthcare organizations to build and deploy AI-powered virtual health assistants and chatbots that can be used to enhance processes, self-service, and cost-reduction efforts. The Healthcare Bot comes with built-in healthcare AI services, including a symptom checker and medical content from known industry resources, and language understanding models that are tuned to understand medical and clinical terminology. For example, you can use screening questions taken directly from the CDC, and incorporate them directly into your website to provide the first step in patient evaluation. Then, if the patient meets the criteria for being at risk, they can be directed straight to your call center to take the next screening steps.

You can customize the built-in functionality and extend it to introduce your own business flows through simple and intuitive visual editing tools. The service aligns to industry and government security and compliance standards such as ISO 27001, 27018, and CSA Gold and GDPR, and provides tools that help ensure HIPAA compliance.

Microsoft offers a range of options depending on maximum messages per month and messages per second, so there is an affordable option to meet the needs of any sized organization.

For more information about enhancing your systems to handle the challenge of the COVID-19 pandemic, reach out to your Sirius representative, or contact us.

Explore the Sirius Healthcare Pulse – Your guide to rapidly respond to COVID-19